Today, on behalf of the National Forum Value & Access Steering Committee and partners, Executive Director John Clymer presented comments to the Institute for Clinical and Economic Review’s (ICER’s) Midwest Comparative Effectiveness Public Advisory Council meeting on its review of high cholesterol treatments.
The comments were based on earlier consensus feedback provided by the Value & Access Steering Committee members and partners who represent patients, clinical providers, payers, purchasers, and public health.
